Halo Collective Inc.
Halo Collective Inc.
Your view on HCANF
Overview
What the company does, where it operates, and who runs it.
About Halo Collective Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Marshall Minor
- Headquarters
- 77 King Street West, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Marshall Minor
- Headquarters
- 77 King Street West, Toronto, ON, CA
Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. It also offers edible products, including cannabis-infused gummies and a syrup-based drink in California and Oregon.
In addition, the company markets branded and private label products. It sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. The company serves licensed retailers and wholesalers. It has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon.
The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is headquartered in Toronto, Canada.
Past Reports
Historical coverage archive.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Halo Collective Inc., and the rating behind it. HCANF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Halo Collective Inc.. Starting points for Halo Collective Inc.: EPS -$10.55, beta 4.18 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Halo Collective Inc.. Halo Collective Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Halo Collective Inc.. Trailing twelve-month EPS for Halo Collective Inc. stands at -$10.55. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Halo Collective Inc.. Halo Collective Inc. has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Halo Collective Inc. valued side by side against its closest peers. Halo Collective Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Halo Collective Inc., and how their positions are changing. At a $15,081 market value, institutional positions materially move Halo Collective Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Halo Collective Inc. executives and directors. Shares of Halo Collective Inc. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Halo Collective Inc.. Halo Collective Inc. is a $15,081 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Halo Collective Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Halo Collective Inc.. Coverage tracks Halo Collective Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.